MENU
Aim higher

MM-HUMAB

Natural human monoclonal antibodies against Fibroblast Activation Protein to treat multiple myeloma

Start date: 
01-07-2015
Project Duration: 
24months
Technological Area: 
Pharmaceutical Products / Drugs
Market Area: 
Monoclonal Antibodies and Hybridomas